MASIMO CORP (MASI) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, MASIMO CORP's filing signal turned positive.

Masimo Corporation is a global medical technology company specializing in noninvasive patient monitoring technologies, hospital automation, and connectivity solutions. The company's core offerings include its proprietary Masimo Signal Extraction Technology (SET) pulse oximetry and advanced rainbow Pulse CO-Oximetry, which measure parameters beyond oxygen saturation and pulse rate, such as noninvasive hemoglobin. Masimo's technologies are integrated into a range of devices, from bedside monitors to handheld units, and are supported by platforms like Masimo Hospital AutomationTM and Masimo SafetyNet(R) to enhance patient care delivery. The company primarily serves hospitals and healthcare providers through a direct sales force and OEM partners, with a strategic focus on innovation and expanding its reach into new healthcare markets.

Revenue is primarily driven by the sale of its noninvasive monitoring technologies, including sensors, cables, and patient monitors, as well as its hospital automation and connectivity solutions. Sales are generated through direct sales channels, distributors, and original equipment manufacturer (OEM) partners.